Connect to other sites within the UBM Medica Network
HOPE-3: Blood Pressure Lowering Alone Fails to Deliver For Some
Although results of the hypertension portion of HOPE-3 were disappointing, many caveats are offered to explain the outcome.
Management of AF Patients with Prior ICH – Race Specific Recommendations for High-Risk Patients
Results of a large Taiwanese registry analysis could open discussion around avoidance of oral anticoagulants in post-ICH patients.
New Analyses Only Partly Defuse ROCKET-AF Trial Concerns
Critics continue to call for independent analysis by outside investigators not involved with the original trial.
7 Modifiable Risk Factors for Atrial Fibrillation
Find data here on obesity, exercise, and OSA, plus 4 more factors that increase the risk for AF and other CV disease.
ROCKET-AF Trial Results Under Fire
Concern that equipment error may have led to higher doses of warfarin than necessary call the huge trial's findings into question.
Anticoagulant Use Among Afib Patients Wanes Over Time
Study results presented at the 2015 AHA meeting reinforce, once again, the critical role of persistent patient education on treatment adherence.
Risk of Atrial Fibrillation Increased in HFpEF
Data from a recent study suggest that paroxysmal AF may be underdiagnosed in patients with heart failure and preserved ejection fraction.
12 Bits On Chocolate and Health
Is eating chocolate good for your patients’ health or bad? Savor these slides for a concise summary of this favorite food’s medicinal pros and cons.
Cardiology Update: 6 New Things From ACP
It’s time to rethink aspirin; there’s optimism about the PCSK9 inhibitors; and new help for people with valvular heart disease. What else is new in cardiology?
3 Myths About New Oral Anticoagulants Debunked for Primary Care Physicians
No monitoring necessary; don't use them before electrical cardioversion; and count them out for periprocedural use during AF ablation. Really?
Atrial Fibrillation: More Than an Electrical Problem
A small study highlights a big point: manage risk factors that affect the atrial fibrillation substrate and ablation therapy success rates improve (ARREST-AF Cohort Study).
By clicking Accept, you agree to become a member of the UBM Medica Community.